FDA approves new indication for treating ocular itching
USA – The FDA has approved Ocular Therapeutix’s Dextenza (dexamethasone 0.4 mg), an...
Read MoreSelect Page
Oct 13, 2021
USA – The FDA has approved Ocular Therapeutix’s Dextenza (dexamethasone 0.4 mg), an...
Read MoreOct 13, 2021
FRANCE – Actemra from Roche has been in high demand since its efficacy in treating severe...
Read MoreOct 13, 2021
FRANCE – The Sanofi Pension Scheme has insured the benefits of approximately 2,900...
Read MoreOct 13, 2021
SOUTH AFRICA – General Electric (GE), leading provider of Healthcare technologies, has...
Read MoreOct 13, 2021
GHANA – The Ministry of Health and partners have collectively called for safe maternal and...
Read MoreOct 13, 2021
EUROPE – European Union member states have unanimously agreed to ban a widely used coloring...
Read MoreOct 13, 2021
NIGERIA – Former Lagos State governor, Babatunde Fashola, and former governor of the Central...
Read MoreOct 13, 2021
UGANDA – A prevalence study conducted in Uganda ha shown that one in five people in Uganda...
Read MoreOct 13, 2021
INDIA – Dr. Agarwal’s Eye Hospitals has announced that it has merged with Maharsahtra-based...
Read MoreOct 13, 2021
AFRICA – Moderna, global Covid-19 vaccine giant, has announced that it is considering...
Read More